Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
After a 251.0% total return over the past five years, UBS Group now sits in an unusual spot where the Excess Returns intrinsic value estimate suggests the stock is roughly in line with fair value, while the earnings multiple view still screens it as undervalued. For investors, the tension is that a strong track record is meeting a valuation picture that looks less like a clear bargain.
UBS Group’s 251.0% five year return highlights how much of the easy upside may already be reflected in the price.
Recent news around US banking expansion and partnerships in private markets and tokenized payments can support confidence in future earnings, while evolving capital rules and crisis conversion mechanics for debt into equity may add uncertainty to how shareholders are diluted in stress scenarios.
With a value score of 2 out of 6, UBS Group screens as not especially cheap on the broader cross checks even though some valuation models point to upside.
The issue now is whether UBS Group’s current price already reflects its longer term return profile, or if the apparent discount on some metrics still leaves room for further gains.
Where Does UBS Group Sit on Excess Returns?
The Excess Returns model starts by comparing what UBS Group earns on its equity to the return investors require. In this case, an average return on equity of 13.64% on a book value base of CHF29.72 per share and a stable EPS estimate of CHF4.45 suggests the bank is generating an excess return of CHF1.51 per share over a cost of equity of CHF2.94. That excess is capitalized on a stable book value of CHF32.63 per share to arrive at an intrinsic value estimate of about CHF40.62.
Compared with the current share price, this implies UBS Group appears to be around 9.0% overvalued on this model, so the market is pricing the stock slightly above what these excess returns support. Because the SEC cleared UBS Group’s crisis debt to equity conversion plan, investors may be accepting a premium despite the dilution mechanics that can apply in stress, which this type of model does not directly capture.
On balance, the Excess Returns model points to UBS Group trading roughly fairly valued, with only a modest premium to its intrinsic value estimate.
UBS Group is fairly valued according to our Excess Returns, but this can change at a moment’s notice. Track the value in your watchlist or portfolio and be alerted on when to act.
Story Continues
UBSG Discounted Cash Flow as at Jul 2026
Is UBS Group a Bargain on Earnings?
The P/E ratio is a useful way to think about UBS Group because earnings are a central focus for investors in a global bank. UBS Group currently trades on a P/E of 18.7x, which is slightly below the Capital Markets industry average of 17.5x and also below the peer average of 19.9x, so it sits somewhere between sector norms and direct comparisons.
The tailored fair P/E ratio for UBS Group is 23.1x, which reflects what investors might expect to pay given its size, risk profile and profitability. That is higher than the current 18.7x, suggesting the stock trades at a discount to where this framework indicates it could sit, even after a multi year run and recent attention on its capital rules and US expansion.
On this P/E yardstick, UBS Group stock appears undervalued relative to the level indicated by its fundamentals and industry position.
SWX:UBSG P/E Ratio as at Jul 2026
See what the numbers say about this price — find out in our valuation breakdown.
The UBS Group Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives pick up where this UBS Group valuation puzzle leaves off by spelling out which combinations of future growth, margins and earnings would need to play out for the stock to be worth materially more or less than today’s price on the Community page. Each narrative links its number to a clear view on how UBS Group’s growth, profitability and risks might evolve, giving you a reference point you can revisit as fresh information comes through.
The community is split on UBS Group, with one camp seeing meaningful upside left and the other arguing the stock already prices in too much optimism.
Bull case: 12% undervalued
“UBS’s technology investments in AI adoption and infrastructure are showing signs of compounding productivity improvements and at-scale digital client engagement, making UBS a frontrunner in digital wealth servicing and creating powerful operating leverage that is set to boost earnings and net margins beyond current market expectations…”
Read the full Bull Case to see why UBS Group could be undervalued
Bear case: 30% overvalued
“The proposed overhaul of Swiss bank capital regulation would require UBS to hold at least $24 billion, and potentially up to $42 billion, in additional capital at the parent bank and group level, materially depressing returns on equity and limiting the company’s ability to distribute capital to shareholders over the long term…”
Read the full Bear Case to see why UBS Group could be overvalued
Do you think there’s more to the story for UBS Group? Head over to our Community to see what others are saying!
The Bottom Line
For UBS Group, the Excess Returns intrinsic value estimate sits close to the current share price, while the P/E based view still points to the stock as undervalued. That split reflects different sensitivities; intrinsic value leans on capital intensity and required returns, while the multiple view leans more on how earnings and peers are being priced. The low overall value score suggests investors should treat any apparent discount with caution, since broader cross checks are not especially supportive. The real hinge from here is whether UBS Group can deliver the earnings profile that justifies a stronger multiple without capital rules and crisis conversion terms eroding shareholder appeal.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include UBSG.SW.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com